Cargando…
Range of L5 LDL levels in healthy adults and L5’s predictive power in patients with hyperlipidemia or coronary artery disease
Electronegative L5 low-density lipoprotein (LDL) level may be a useful biomarker for predicting cardiovascular disease. We determined the range of plasma L5 levels in healthy adults (n = 35) and examined the power of L5 levels to differentiate patients with coronary artery disease (CAD; n = 40) or p...
Autores principales: | Chu, Chih-Sheng, Chan, Hua-Chen, Tsai, Ming-Hsien, Stancel, Nicole, Lee, Hsiang-Chun, Cheng, Kai-Hung, Tung, Yi-Ching, Chan, Hsiu-Chuan, Wang, Chung-Ya, Shin, Shyi-Jang, Lai, Wen-Ter, Yang, Chao-Yuh, Dixon, Richard A., Chen, Chu-Huang, Ke, Liang-Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082876/ https://www.ncbi.nlm.nih.gov/pubmed/30089847 http://dx.doi.org/10.1038/s41598-018-30243-w |
Ejemplares similares
-
Effect of Thymoquinone on Renal Damage Induced by Hyperlipidemia in LDL Receptor-Deficient (LDL-R(−)/(−)) Mice
por: Li, Wanjing, et al.
Publicado: (2022) -
Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits K(ATP) channels through CaMKII activation
por: Ma, Yanzhuo, et al.
Publicado: (2020) -
Human electronegative LDL induces mitochondrial dysfunction and premature senescence of vascular cells in vivo
por: Wang, Yu‐Chen, et al.
Publicado: (2018) -
Adiponectin forms a complex with atherogenic LDL and inhibits its downstream effects
por: Kakino, Akemi, et al.
Publicado: (2020) -
Protective role of thymoquinone in hyperlipidemia-induced liver injury in LDL-R(−/−)mice
por: Wang, Fei, et al.
Publicado: (2023)